Cyclopharm Ltd has released a press release.
Cyclopharm Capital Raising Investor Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Cyclopharm
- Cyclopharm Successfully Completes A$14 million Placement
- CYC Unaudited Trading Update - Preliminary FY2025 Results
- Trading Halt
- COPD Study Leveraging Technegas and AI-Driven Lung Analysis
- Technegas Recognised in Updated Clinical Guideline
Later from Cyclopharm
- Technegas Approved at the US National Institutes of Health
- Technegas US Footprint Expanding Across Four Regions
- Preliminary Final Report
- CYC Signs Enterprise Agreement with UPHS
- CYC Secures Multi-Site Agreement with Northwestern Medicine
Follow Cyclopharm into a list and get an email when it puts out news.
Follow Cyclopharm